Beta-amyloid (Aβ) deposition and vascular dysfunction are important contributors to the pathogenesis in Alzheimer's disease (AD). However, the spatio-temporal relationship between an altered oxygen metabolism and Aβ deposition in the brain remains elusive. Here we provide novel in-vivo estimates of brain Aβ load with Aβ-binding probe CRANAD-2 and measures of brain oxygen saturation by using multi-spectral optoacoustic imaging (MSOT) and perfusion imaging with magnetic resonance imaging (MRI) in arcAβ mouse models of AD. We demonstrated a decreased cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO 2 ) in the cortical region of the arcAβ mice compared to wildtype littermates at 24 months. In addition, we showed proof-of-concept for the detection of cerebral Aβ deposits in brain from arcAβ mice compared to wild-type littermates.
INTRODUCTION
Abnormal accumulation of fibrillary β-amyloid (Aβ) plaques in brain is one of the pathological hallmarks of AD. The interaction between Aβ deposition and cerebrovascular dysfunction plays a pivotal role in the disease pathogenesis. Understanding the spatio-temporal relationships of regional brain hemodynamics (parameters such as CBF, oxygen saturation (SO 2 ), oxygen extract fraction (OEF), and CMRO 2 with Aβ deposition in vivo might help to elucidate the disease mechanism. The advent of non-invasive imaging modalities has enabled the visualizing Aβ deposition and brain hemodynamic in animal models. Different methods e.g. positron emission tomography (PET)- 15 O [1] have been applied to quantify the brain oxygenation state. PET [2] [3] [4] , single photon emission computed tomography [5] , near-infrared fluorescent (NIRF) [6, 7] , fluorescent molecular tomography [8] , MRI [9, 10] , and multi-photon imaging [11] together with appropriate probes have been applied for detecting Aβ deposits in several AD mouse models of amyloidosis. NIRF using different probes [12] such as AOI987 [6, 8] , THK265 [13] , and CRANAD-2 [14] for brain Aβ imaging in animal models have been reported. However, planar NIRF imaging is limited by a low spatial resolution and cannot discriminate signals from the depth. Brain hemodynamics have been evaluated using a range of optical imaging modalities [15, 16] such as photoacoustic microscopy [17, 18] . However these techniques are limited by small field-of-view (FOV), depth penetration and are invasive.
MSOT allows the non-invasive assessment of photoabsorbing molecules relatively deep in tissue (mm range) [19] including the brains of rats and mice [20] . By using multiple wavelengths for illuminating and spectral unmixing algorithms, MSOT resolves signal contribution from different photoabsorbing molecules in tissue simultaneously based on their spectral properties [21] . Measures of hemoglobin in animal models has been used as endogenous markers for total blood volume and oxygen saturation etc. with MSOT [22] . Here we provide a novel non-invasive estimate of brain Aβ load using amyloid probe CRANAD-2 and hemodynamic alternations by using MSOT in the same animal, and together with cerebral perfusion imaging estimates of OEF in arcAβ mouse model of AD.
METHODS

Animal model
Transgenic arcAβ mice overexpressing the human APP695 transgene containing the Swedish (K670N/M671L) and Arctic (E693G) mutation under the control of the prion protein promoter and age-matched non-transgenic C57BL6 littermates were used (24-months of age, n = 10 per group). All experiments were performed in accordance with the Swiss Federal Act on Animal Protection and were approved by the Cantonal Veterinary Office Zurich (permit number: ZH090-16). All procedures fulfilled the ARRIVE guidelines on reporting animal experiments.
MRI
CBF was assessed in arcAβ and wild-type mice of 24-months under resting conditions using an arterial spin labeling (ASL) method with a flow sensitive alternating inversion recovery technique using a 7/16 small animal MR Pharmascan (Bruker Biospin GmbH, Ettlingen, Germany). A spin-echo planar imaging sequence preceded by a 180° hyperbolic secant RF inversion pulse was used with echo time = 12.47 ms; relaxation time = 12000 ms; flip angle = 90°. One axial slide of 1 mm thickness was acquired with a FOV = 20 × 20 mm; image matrix = 128 × 96, with a spatial resolution = 156 μm × 208 μm. Inversion parameters were: inversion slab thickness = 4 mm, slice margin = 1.5 mm. Sixteen images with increasing inversion times (10 s, 50-3000 ms) were obtained for T 1 calculations, with a total scan time of 11 min and 55 s. Inversion recovery data from the imaging slices was acquired after selective inversion interleaved with nonselective inversion. T 2 -weighted MR images were obtained using a spin echo sequence (TurboRARE) with echo time = 3 ms, repetition time = 6 ms, 100 averages, slice thickness = 1 mm, FOV = 2.56×1.28 cm 2 , matrix size = 256×128, an inplane resolution = 100 µm×100 µm. A T 2 -weighted anatomical image was acquired at the same position as the ASL slice for each mouse for defining the regions of interest (ROI). For co-registration with MSOT image, multi-slice T 2 -weighted images were acquired using the same parameters. The Paxinos mouse brain atlas was used as the anatomical reference for scan and analysis.
MSOT amyloid and hemodynamics
The MSOT inVision 128 small animal imaging system (iThera Medical GmbH, Munich, Germany) was used for measurement of brain amyloid deposition and oxygenation as described previously [23] . A tunable (680-980 nm) optical parametric oscillator pumped by an Nd:YAG laser provides 9 ns excitation pulses at a framerate of 10 Hz with 10 ms wavelength tuning speed and a peak pulse energy of 100 mJ at 730 nm. Ten arms with an optical fiber bundle each, provide even illumination of a ring-shaped light strip of 8 mm width. Mice were anesthetized with an oxygen/air mixture (200:800 mL/min) with 4 % isoflurane and maintained with an oxygen/air mixture (100:400 mL/min) with 1.5 % isoflurane supplied via a nose cone. The body temperature of the mouse was maintained at 36.5 °C during preparation and measurement. The fur overlying the head was removed. Mice were epilated around the head and placed in a mouse holder in supine position. Ultrasound gel (Diagramma, Switzerland) was applied to the mouse head for ultrasonic coupling and the animals were wrapped in a polyethylene membrane. For the mice underwent only hymodynamic measurement, images were acquired at wavelengths 715, 730, 760, 800, 850 nm, with 10 averages at different positions from eye to cerebellum, For the amyloid distribution measurement, mice were cannulated and injected intravenously at the tail vain with probe CRANAD-2 (2.0 mg/kg, 10 % DMSO, 90 % polyethylene glycol). Images were acquired at wavelengths 680, 685, 690, 695, 700, 715, 730, 760, 800, 850 nm with 10 averages at different positions from eye to cerebellum, approximately 7 minutes for each scan. Images were acquired before injection, and up to 240 minutes postinjection.
NIRF imaging
To verify the binding of CRANAD-2 and the amyloid distribution in the mouse brain, 24-month-old wild-type and arcAβ mice measured with a Maestro 500 multispectral imaging system (Cambridge Research & Instruments Inc., USA). During measurements mice were anesthetized with 2 % isoflurane in an oxygen/air mixture (100:400 mL/min). The system was equipped with a band pass filter (615-665 nm) for excitation and a longpass filter (> 700 nm) for signal detection. The head of the mice were placed in a reproducible manner and NIRF images were spectrally unmixed using the CRI Maestro software. A ROI was drawn over the mouse brain and the average signal intensity was calculated.
MRI data analysis
For CBF data analysis, ROIs were delineated over the cerebral cortex and thalamus on axial T 2 -weighted anatomical scans and transferred to CBF maps using AFNI (NIH, USA). For CBF calculation, the flow sensitive alternating inversion recovery images with different T 1selective were realigned and resliced over the first T 1 using a rigid-body model. Determination of T 1selective and T 1global were performed by fitting the averaged signal intensities in each ROI with 3-parameters mono-exponential T 1 relaxation curve. CBF in ROIs was calculated from both T 1 values using the equation (1) in MATLAB R2015b (Mathworks, MA, USA):
CBF/λ = T 1global /T 1blood × (1/T 1selective -1/T 1global ) (1) where CBF is the amount of blood passing through the brain tissue in mL/100 g/min, is the blood/tissue partition coefficient for water [24] , assumed to be 0.9 mL/g [25] and T 1blood was assumed to be 2.007 s at 7 T [26].
MSOT image reconstruction and spectral unmixing
MSOT images were reconstructed using a backprojection algorithm with a non-negativity constraint imposed during inversion. The resulting reconstructed MSOT images were overlaid with T 2 -weighted anatomical scans for reference. ( 3) The coronal views of SO 2 were generated using ImageJ (NIH, U.S.A.). CMRO 2 was calculated using maximal amount of oxygen carrying capacity of a unit volume of blood (Ca) 833.7 μmol O 2 /100 mL blood [27] .
CMRO2=CBF × (S a O 2 -S v O 2 ) × C a (4)
For the analysis of MSOT amyloid imaging data, ROIs delineating over the cortex of the mouse brain was used. Time course of cortical uptake of CRANAD-2 was quantified. Mice with pigment deposits in the scalp were excluded from the analysis due to interference with MSOT quantification.
Statistics
All data are present as mean ± standard deviation (SD). One-way ANOVA with post hoc Bonferroni correction for multiple comparisons was used for group analysis (Graphpad Prism 6.0, CA, U.S.A). Non-parametric Mann-Whitney unpaired student t test was used for group comparison. Significance was set at * p < 0.05, ** p < 0.01, *** p < 0.001.
RESULTS
Hypoperfusion/reduced CBF in aged arcAβ mouse
CBF measurements with ASL were performed in arcAβ and wild-type mice to assess differences in cerebral perfusion due to Aβ deposition and cerebral amyloid angiopathy. ROI analysis of CBF maps showed 30 % reduction in the cortex, but not in the thalamus of arcAβ compared wild-type mice. 
Impaired hemodynamics and CMRO 2 by MSOT in arcAβ mouse
MSOT of cerebral hemodynamics in the brain of arcAβ and wild-type mice were performed. Hb and HbO 2 maps were computed from spectral unmixed data. OEF was calculated from SO 2 values of the artery (middle cerebral artery) and vein (sagittal sinus) did not differ between the two groups (n = 8 per group). CMRO 2 values in the cortical region were lower in the arcAβ compared to age-matched wild-type mice, suggesting dysfunction of cerebral oxygen metabolism in arcAβ mice. 
Increased amyloid probe CRANAD-2 signal in arcAβ mouse by MSOT and NIRF imaging
Proof-of-concept study showed increased level of CRANAD-2 signals in the cortical brain regions of arcAβ mice, indicating Aβ accumulation, while other brain regions seemed largely devoid of signal. The signal peak at 10-15 minutes in the NIRF and around 60 minute in the MSOT measure. There is complete washout after 4 hours from the mouse brain. The less fold of signal increase was observed using MSOT compared to NIRF. 
DISCUSSION
In this study, we demonstrated cortical Aβ deposits and cerebral oxygenation dysfunction in arcAβ mouse at 24-month using MSOT. However, it should be noted that MSOT does not provide absolute quantification of SO 2 . The confounding factors for the MSOT imaging might include significant light absorption in the brain and extracerebral tissue that affects the incident light fluence and signal amplitude [28] . Previous imaging studies in transgenic AD mouse model have showed that advanced disease stage involves cerebral amyloidosis, cerebral amyloid angiopathy in the brain and decreased cortical CBF [3] . Due to the inability of the vascular system to compensate the decrease in CBF and oxygen delivery by increasing the OEF, CMRO 2 values were found to be significantly decreased in our study.
For the MSOT amyloid imaging in AD mouse model, more advanced compartment pharmacokinetic modeling are required for accurate quantification of the uptake in the brain. Additional evaluations in the AD transgenic and wild-type mice are needed to fully establish the new imaging assays.
CONCLUSIONS
The study shows that an advanced stage of cerebral amyloidosis in arcAβ mice is accompanied by a decreases in levels of CBF, which translates into reduced value for CMRO 2 , as OEF has been found unaffected by the disease process. Thus, MSOT constitutes a potential tool for dissecting the interaction between hemodynamic dysfunction and amyloid neuropathology within the same object and can be used for the evaluation of potential therapeutic treatments in mouse models of AD.
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